355 related articles for article (PubMed ID: 9513600)
1. Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.
Cervini LA; Donaldson CJ; Koerber SC; Vale WW; Rivier JE
J Med Chem; 1998 Feb; 41(5):717-27. PubMed ID: 9513600
[TBL] [Abstract][Full Text] [Related]
2. Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study.
Kornreich WD; Galyean R; Hernandez JF; Craig AG; Donaldson CJ; Yamamoto G; Rivier C; Vale W; Rivier J
J Med Chem; 1992 May; 35(10):1870-6. PubMed ID: 1316969
[TBL] [Abstract][Full Text] [Related]
3. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
[TBL] [Abstract][Full Text] [Related]
4. Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges.
Rivier J; Lahrichi SL; Gulyas J; Erchegyi J; Koerber SC; Craig AG; Corrigan A; Rivier C; Vale W
J Med Chem; 1998 Jul; 41(14):2614-20. PubMed ID: 9651165
[TBL] [Abstract][Full Text] [Related]
5. Potent agonists of growth hormone-releasing hormone. II.
Zarandi M; Serfozo P; Zsigo J; Deutch AH; Janaky T; Olsen DB; Bajusz S; Schally AV
Pept Res; 1992; 5(4):190-3. PubMed ID: 1421808
[TBL] [Abstract][Full Text] [Related]
6. Constrained corticotropin-releasing factor antagonists with i-(i + 3) Glu-Lys bridges.
Miranda A; Lahrichi SL; Gulyas J; Koerber SC; Craig AG; Corrigan A; Rivier C; Vale W; Rivier J
J Med Chem; 1997 Oct; 40(22):3651-8. PubMed ID: 9357532
[TBL] [Abstract][Full Text] [Related]
7. Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs.
Felix AM; Lu YA; Campbell RM
Int J Pept Protein Res; 1995; 46(3-4):253-64. PubMed ID: 8537179
[TBL] [Abstract][Full Text] [Related]
8. Potent trypsin-resistant hGH-RH analogues.
Izdebski J; Witkowska E; Kunce D; Orłowska A; Baranowska B; Wolińska-Witort E
J Pept Sci; 2004 Aug; 10(8):524-9. PubMed ID: 15347139
[TBL] [Abstract][Full Text] [Related]
9. Bioactivities and secondary structures of constrained analogues of human parathyroid hormone: cyclic lactams of the receptor binding region.
Barbier JR; Neugebauer W; Morley P; Ross V; Soska M; Whitfield JF; Willick G
J Med Chem; 1997 Apr; 40(9):1373-80. PubMed ID: 9135034
[TBL] [Abstract][Full Text] [Related]
10. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor.
Beyermann M; Fechner K; Furkert J; Krause E; Bienert M
J Med Chem; 1996 Aug; 39(17):3324-30. PubMed ID: 8765516
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions.
Cervini L; Theobald P; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
J Med Chem; 1999 Feb; 42(4):761-8. PubMed ID: 10052982
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone.
Zarandi M; Horvath JE; Halmos G; Pinski J; Nagy A; Groot K; Rekasi Z; Schally AV
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12298-302. PubMed ID: 7991622
[TBL] [Abstract][Full Text] [Related]
13. Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.
Rivier J; Gulyas J; Corrigan A; Martinez V; Craig AG; Taché Y; Vale W; Rivier C
J Med Chem; 1998 Dec; 41(25):5012-9. PubMed ID: 9836619
[TBL] [Abstract][Full Text] [Related]
14. New analogs of human growth hormone-releasing hormone (1-29) with high and prolonged antagonistic activity.
Toth K; Kovacs M; Zarandi M; Halmos G; Groot K; Nagy A; Kele Z; Schally AV
J Pept Res; 1998 Feb; 51(2):134-41. PubMed ID: 9516049
[TBL] [Abstract][Full Text] [Related]
15. Potent long-acting alkylated analogs of growth hormone-releasing factor.
Murphy WA; Coy DH
Pept Res; 1988; 1(1):36-41. PubMed ID: 2908793
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
[TBL] [Abstract][Full Text] [Related]
17. Potent agonists of growth hormone-releasing hormone. Part I.
Zarandi M; Serfozo P; Zsigo J; Bokser L; Janaky T; Olsen DB; Bajusz S; Schally AV
Int J Pept Protein Res; 1992 Mar; 39(3):211-7. PubMed ID: 1399259
[TBL] [Abstract][Full Text] [Related]
18. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.
Peggion E; Mammi S; Schievano E; Schiebler L; Corich M; Rosenblatt M; Chorev M
Biopolymers; 2003 Mar; 68(3):437-57. PubMed ID: 12601801
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
Arttamangkul S; Ishmael JE; Murray TF; Grandy DK; DeLander GE; Kieffer BL; Aldrich JV
J Med Chem; 1997 Apr; 40(8):1211-8. PubMed ID: 9111295
[TBL] [Abstract][Full Text] [Related]
20. Functional evidence for an intramolecular side chain interaction between residues 6 and 10 of receptor-bound parathyroid hormone analogues.
Shimizu N; Petroni BD; Khatri A; Gardella TJ
Biochemistry; 2003 Mar; 42(8):2282-90. PubMed ID: 12600195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
